Download - Max International Virtual Office

PRODuCT
CELLGEVITY
Keeping Max in the lead
Dave Bagley
Max International’s acquisition of CellGevity’s technology and assets will keep us on the cutting edge of
technology, research, development and distribution for years to come. It is part of Max’s ongoing commitment
to become the global glutathione leader.
“Selling mediocre products to get a paycheck may be acceptable at other companies but it is not allowed here,” said dave
Bagley, the Vice President of Product Development. “Anti-aging products are projected to rise in sales $30.7 billion in 2009,
so worldwide acceptance of what we have to offer should come as no surprise in the coming years.”
dave sat down with CellGevity Co-founders dr. Herb Nagasawa, dr. Scott Nagasawa and Scott Momii. dr. Herb Nagasawa’s
glutathione research over the last 30 years is at the core of CellGevity and is the reason it came into existence. “I can tell you
without equivocation that glutathione is the most important endogenous antioxidant there is,” dr. Herb Nagasawa said. “It
is manufactured by the body and is the only antioxidant that can recycle itself.”
From compound to partnership
It all started when Herb placed a phone call to his son, Scott Nagasawa. Herb enthusiastically asked Scott if he was
interested in buying the rights to his compounds developed at the University of Minnesota and the VA Medical Center,
where the research was conducted.
“I felt this was out of character for Herb because he never got excited about anything and never really shared the results of his
research with us and was told this was by far his best discovery.” Scott said. “ These compounds were not only effective when
given intravenously but equally effective when given orally. This was extraordinary data. He repeated the experiment two additional
times and got similar results. He felt this compound needed to be commercialized and be available to the general public.”
Thus CellGevity came to be. Scott Momii got involved because of his extensive business background. He became the CEO of
CellGevity and oversaw all aspects of the business development and operations, including manufacturing, patent management,
and licensing. It didn’t take much to convince him that this was a team and a company he wanted to be associated with.
9